drugset / Trial / NCT04772729

Does the Use of Fiasp vs. Asp Lead to the Prolonged TIR in Children With Type 1 Diabetes?

NCT04772729

Phase 4 Unknown 77 enrolled Medical University of Warsaw
RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the study is to assess whether the implementation of faster insulin aspart in children with Type 1 diabetes treated with intensive insulin therapy with the use of an insulin pump and using Real Time Continuous Glucose Monitoring (RT-CGM) systems leads to prolonged time in range (TIR) compared to insulin aspart.

Timeline

Start
2021-03-01
Primary completion
2023-03-01
Completion
2024-03-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin faster aspart Unknown Subcutaneous
Subject insulin aspart Protein / enzyme biologic Subcutaneous